DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Thrombolysis assisted PCI Bonnie H. Weiner MD MSEC MBA FSCAI Past President SCAI Professor of Medicine Director Interventional Cardiology Research St Vincent.
Documents Thrombolysis assisted PCI Bonnie H. Weiner MD MSEC MBA FSCAI Past President SCAI Professor of...

Thrombolysis assisted PCI Bonnie H. Weiner MD MSEC MBA FSCAI Past President SCAI Professor of Medicine Director Interventional Cardiology Research St Vincent Hospital @ Worcester…

James J. Ferguson, MD
Documents James J. Ferguson, MD

“Vulnerable” Plaque and Acute Coronary Syndromes Rupture Thrombosis Occlusion Prothrombin Fibrinogen Fibrin monomer Tissue Factor VIIa VII VIIa/TF IX IXa X Xa Fibrin…

Claudio Moretti, M.D. Division of Cardiology, University of Turin, Turin, Italy
Documents Claudio Moretti, M.D. Division of Cardiology, University of Turin, Turin, Italy

Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology, University…

Patient Oriented Therapy for STE-MI
Documents Patient Oriented Therapy for STE-MI

Patient Oriented Therapy for STE-MI Seçkin Pehlivanoğlu, MD Başkent University, İstanbul Hospital Patient Oriented Therapy for STE-MI Q: What are the spesific conditions…

Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Documents Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines...

Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter) Background. Surgical atrial ablation procedure (MAZE) may restore…

James J. Ferguson, MD The Evolving Standard of Care for Acute Coronary Syndromes 2006.
Documents James J. Ferguson, MD The Evolving Standard of Care for Acute Coronary Syndromes 2006.

“Vulnerable” Plaque and Acute Coronary Syndromes Rupture Thrombosis Occlusion Prothrombin Fibrinogen Fibrin monomer Tissue Factor VIIa VII VIIa/TF IX IXa X Xa Fibrin…

When, how & why GP IIb/IIIa inhibitors Luca Testa, MD, PhD Istituto Clinico S. Ambrogio IRCCS San Donato, Milano luctes@gmail.com.
Documents When, how & why GP IIb/IIIa inhibitors Luca Testa, MD, PhD Istituto Clinico S. Ambrogio IRCCS San...

When, how & why GP IIb/IIIa inhibitors Luca Testa, MD, PhD Istituto Clinico S. Ambrogio IRCCS San Donato, Milano [email protected] Derived from a murine monoclonal antibody.…

Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting.
Documents Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety.....

Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel-Eluting…

When, how & why GP IIb/IIIa inhibitors
Documents When, how & why GP IIb/IIIa inhibitors

When, how & why GP IIb/IIIa inhibitors Luca Testa, MD, PhD Istituto Clinico S. Ambrogio IRCCS San Donato, Milano [email protected] Derived from a murine monoclonal antibody.…

ACS Management and ESC Guidelines
Documents ACS Management and ESC Guidelines

OASIS in ACS: with Updates on 2011 ESC Guidelines on Anticoagulation Donato Maranon, MD, FPCP, FPCC, FACC Antiplatelet agents Anticoagulants Revascularization / Reperfusion…

Popular Categories
Relevant Tags